These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 33592208)
1. Femoral-popliteal peripheral artery disease: From symptom presentation to management and treatment controversies. Krawisz AK; Raja A; Secemsky EA Prog Cardiovasc Dis; 2021; 65():15-22. PubMed ID: 33592208 [TBL] [Abstract][Full Text] [Related]
2. The Safety of Paclitaxel-Coated Devices for Patients with Peripheral Artery Disease. Krawisz AK; Secemsky EA Curr Cardiol Rep; 2021 Mar; 23(5):48. PubMed ID: 33738616 [TBL] [Abstract][Full Text] [Related]
3. Robustness of Longitudinal Safety and Efficacy After Paclitaxel-Based Endovascular Therapy for Treatment of Femoro-Popliteal Artery Occlusive Disease: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. D'Oria M; Mastrorilli D; Secemsky E; Behrendt CA; Veraldi G; DeMartino R; Mani K; Budtz-Lilly J; Scali S; Saab F; Calvagna C; Mezzetto L; Ruaro B; Lepidi S Ann Vasc Surg; 2024 Apr; 101():164-178. PubMed ID: 38154491 [TBL] [Abstract][Full Text] [Related]
4. Increased mortality with paclitaxel-eluting stents is driven by lesion length. Mathlouthi A; Yei KS; Naazie I; Bertges DJ; Malas MB J Vasc Surg; 2021 Feb; 73(2):548-553.e2. PubMed ID: 32615286 [TBL] [Abstract][Full Text] [Related]
5. Outcomes of treatment with paclitaxel-coated devices for peripheral arterial disease. Kim TI; Kiwan G; Mohamedali A; Zhang Y; Mena-Hurtado C; Mojibian H; Guzman RJ; Ochoa Chaar CI J Vasc Surg; 2021 Mar; 73(3):911-917. PubMed ID: 33038480 [TBL] [Abstract][Full Text] [Related]
6. Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain. Zeller T; Brodmann M; Micari A; Keirse K; Peeters P; Tepe G; Scheinert D; Jaff MR; Rocha-Singh KJ; Li P; Schmahl R; Ansel GM; Circ Cardiovasc Interv; 2019 Jan; 12(1):e007730. PubMed ID: 30630355 [No Abstract] [Full Text] [Related]
7. Efficacy and one-year outcomes of Luminor® paclitaxel-coated drug-eluting balloon in the treatment of popliteal artery atherosclerosis lesions. Pecoraro F; Dinoto E; Pakeliani D; Mirabella D; Ferlito F; Bajardi G Ann Vasc Surg; 2021 Oct; 76():370-377. PubMed ID: 33951533 [TBL] [Abstract][Full Text] [Related]
8. Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain: 2-Year Results From the IN.PACT Global Study. Micari A; Brodmann M; Keirse K; Peeters P; Tepe G; Frost M; Wang H; Zeller T; JACC Cardiovasc Interv; 2018 May; 11(10):945-953. PubMed ID: 29798770 [TBL] [Abstract][Full Text] [Related]
9. Paclitaxel exposure and long-term mortality of patients treated with the Zilver PTX drug-eluting stent. Stern JR; Tran K; Chandra V; Harris EJ; Lee JT Vascular; 2021 Aug; 29(4):567-573. PubMed ID: 33054678 [TBL] [Abstract][Full Text] [Related]
10. One-Year Clinical Outcomes of the Legflow Drug-Coated Balloon for the Treatment of Femoropopliteal Occlusions Registry. Stabile E; Gerardi D; Magliulo F; Zhelev D; Chervenkoff V; Taeymans K; Kotasov D; Goverde P; Giugliano G; Trimarco B; Esposito G J Endovasc Ther; 2019 Feb; 26(1):26-30. PubMed ID: 30760132 [TBL] [Abstract][Full Text] [Related]
12. Mortality Risk Following Application of a Paclitaxel-Coated Stent in Femoropopliteal Lesions. Katsuki T; Takahara M; Soga Y; Okamoto S; Iida O; Fujihara M; Kawasaki D; Ando K J Endovasc Ther; 2019 Oct; 26(5):593-599. PubMed ID: 31431154 [TBL] [Abstract][Full Text] [Related]
13. Primary Patency of Long-Segment Femoropopliteal Artery Lesions in Patients with Peripheral Arterial Occlusive Disease Treated with Paclitaxel-Eluting Technology. Phair J; Carnevale M; Lipsitz EC; Shariff S; Scher L; Garg K Ann Vasc Surg; 2020 Jul; 66():595-600. PubMed ID: 31863948 [TBL] [Abstract][Full Text] [Related]
14. Early Post-Registry Experience With Drug-Eluting Stents in the Superficial Femoral Artery. Wooster M; Dansey K; Shames M Vasc Endovascular Surg; 2016 Feb; 50(2):80-3. PubMed ID: 26912397 [TBL] [Abstract][Full Text] [Related]
15. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study. Reijnen MMPJ; van Wijck I; Zeller T; Micari A; Veroux P; Keirse K; Lee SW; Li P; Voulgaraki D; Holewijn S J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726 [TBL] [Abstract][Full Text] [Related]
16. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease. Tran K; Ullery BW; Kret MR; Lee JT Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688 [TBL] [Abstract][Full Text] [Related]
17. Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The IN.PACT Global Study De Novo In-Stent Restenosis Imaging Cohort. Brodmann M; Keirse K; Scheinert D; Spak L; Jaff MR; Schmahl R; Li P; Zeller T; JACC Cardiovasc Interv; 2017 Oct; 10(20):2113-2123. PubMed ID: 29050631 [TBL] [Abstract][Full Text] [Related]
18. Mortality After Paclitaxel Coated Balloon Angioplasty and Stenting of Superficial Femoral and Popliteal Artery in the Vascular Quality Initiative. Bertges DJ; Sedrakyan A; Sun T; Eslami MH; Schermerhorn M; Goodney PP; Beck AW; Cronenwett JL; Eldrup-Jorgensen J Circ Cardiovasc Interv; 2020 Feb; 13(2):e008528. PubMed ID: 32069110 [TBL] [Abstract][Full Text] [Related]
19. Paclitaxel and Mortality Following Peripheral Angioplasty: An Adjusted and Case Matched Multicentre Analysis. Saratzis A; Lea T; Yap T; Batchelder A; Thomson B; Saha P; Diamantopoulos A; Saratzis N; Davies R; Zayed H Eur J Vasc Endovasc Surg; 2020 Aug; 60(2):220-229. PubMed ID: 32370918 [TBL] [Abstract][Full Text] [Related]
20. The current status of drug-coated devices in lower extremity peripheral artery disease interventions. Amlani V; Falkenberg M; Nordanstig J Prog Cardiovasc Dis; 2021; 65():23-28. PubMed ID: 33587964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]